Merck Plans To ‘Tuck In’ Imago And Its Phase III-Ready Hematologic Candidate

 
• By Joseph Haas
  
Myeloproliferative neoplasms
Merck will acquire Imago's lead candidate for myeloproliferative neoplasms • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business